Similar Articles for PMID: 20463586

Year	Number of Results
1998	2
1999	1
2001	2
2002	2
2003	2
2004	2
2005	2
2006	2
2007	4
2008	2
2009	11
2010	8
2011	6
2012	2
2013	3
2014	1
2015	2
2016	2
2017	2
2018	1
2019	2
2020	0

1

Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS.

Irvine SL, Hummelen R, Hekmat S, Looman CW, Habbema JD, Reid G. Irvine SL, et al. J Clin Gastroenterol. 2010 Oct;44(9):e201-5. doi: 10.1097/MCG.0b013e3181d8fba8. J Clin Gastroenterol. 2010. PMID: 20463586

2

Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients.

Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G. Anukam KC, et al. J Clin Gastroenterol. 2008 Mar;42(3):239-43. doi: 10.1097/MCG.0b013e31802c7465. J Clin Gastroenterol. 2008. PMID: 18223503 Clinical Trial.

3

Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania.

Irvine SL, Hummelen R, Hekmat S. Irvine SL, et al. Nutr Res. 2011 Dec;31(12):875-81. doi: 10.1016/j.nutres.2011.10.005. Nutr Res. 2011. PMID: 22153512

4

Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada.

Hemsworth JC, Hekmat S, Reid G. Hemsworth JC, et al. Gut Microbes. 2012 Sep-Oct;3(5):414-9. doi: 10.4161/gmic.21248. Epub 2012 Jul 24. Gut Microbes. 2012. PMID: 22825497 Clinical Trial.

5

Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients.

Hummelen R, Hemsworth J, Changalucha J, Butamanya NL, Hekmat S, Habbema JD, Reid G. Hummelen R, et al. Nutrients. 2011 Oct;3(10):897-909. doi: 10.3390/nu3100897. Epub 2011 Oct 21. Nutrients. 2011. PMID: 22254084 Free PMC article. Clinical Trial.

6

Development of a locally sustainable functional food for people living with HIV in Sub-Saharan Africa: laboratory testing and sensory evaluation.

Van Tienen A, Hullegie YM, Hummelen R, Hemsworth J, Changalucha J, Reid G. Van Tienen A, et al. Benef Microbes. 2011 Sep;2(3):193-8. doi: 10.3920/BM2011.0024. Benef Microbes. 2011. PMID: 21986358

7

Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.

Onen NF, Overton ET, Presti R, Blair C, Powderly WG, Mondy K. Onen NF, et al. HIV Med. 2009 Aug;10(7):439-46. doi: 10.1111/j.1468-1293.2009.00711.x. Epub 2009 May 6. HIV Med. 2009. PMID: 19459993 Free article.

8

Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.

Okano A, Matsuda M, Chiba T, Moriya K, Yamada K, Sugiura W. Okano A, et al. Jpn J Infect Dis. 2002 Apr;55(2):62-5. Jpn J Infect Dis. 2002. PMID: 12082315 No abstract available.

9

Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.

Diabaté S, Alary M. Diabaté S, et al. HIV Med. 2009 Nov;10(10):640-6. doi: 10.1111/j.1468-1293.2009.00736.x. Epub 2009 Jul 29. HIV Med. 2009. PMID: 19659945 Free article.

10

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

Okulicz JF, Grandits GA, Weintrob AC, Landrum ML, Ganesan A, Crum-Cianflone NF, Agan BK, Marconi VC. Okulicz JF, et al. Clin Infect Dis. 2010 Apr 15;50(8):1187-91. doi: 10.1086/651421. Clin Infect Dis. 2010. PMID: 20218878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed